This information was published on 2025-06-30T08:09:46 for IP Right Registration Published.
| Field | Value |
| (210) | 2500412 |
| (220) |
20 Nov 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations for use in the treatment of cancer, autoimmune disease, and immune system-related diseases and disorders; Immunotherapy preparations comprising engineered t-cell receptors; Immunotherapy preparations comprising covalently binding proteins; Immunotherapeutic drugs; Engineered T cell receptors; Covalently binding proteins; Reagents for medical use; Diagnostic reagents for medical use; Diagnostic preparations for medical purposes |
| (540) | Resseptor Therapeutics |
| (550) | Word |
| (730) |
Resseptor Therapeutics Pty Ltd
ACN/ABN 20666187202 |
| (750) |
Resseptor Therapeutics
|
Find out more about publications on the About page.